After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q3 2022 call → NOWe need to determine if management reports that the most important positive developments happened so late in the period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. We need to look for management's own words indicating late-breaking concrete positive events that occurred near the end of the period or after, and that management treats them as the real story the numbers missed. The transcript is from Q3 2022 earnings call (November 14, 2022). The period is Q3 2022 (ended September 30, 2022). The call is in November, so shortly after quarter end. We need to see if management highlights any positive developments that happened late in Q3 or after quarter end, and says that the reported results don't reflect them. Let's scan the transcript for timing references. Dan Passeri: "I'll begin by providing an overview of our competitive and strategic positioning based upon data from both our monotherapy trial of CUE-101 as well as the data just recently reported at SITC from our CUE-101 and KEYTRUDA combination trial." SITC is a conference (Society for Immunotherapy of Cancer) that typically occurs in November. The call is November 14, 2022. So the data was "just recently reported at SITC" - that is after quarter end (Q3 ended Sept 30). So that is a late-breaking event. But is that a "positive development" that is concrete? Yes, they report data from the combination trial. They highlight a 40% objective response rate, etc. They also mention Fast Track designation granted. When was that? They say "The robust data on CUE-101's activity in monotherapy and in combination with pembrolizumab has triggered the granting of Fast Track designation status for the treatment of patients in both first and third line setting." They don't specify when that was granted, but it's likely recent. Also, they mention "we have treated our first patient with CUE-102" - that is a positive development. When did that happen? They say "I'm also happy to report that we have treated our first patient with CUE-102" - that is likely recent, maybe after quarter end? They don't specify timing. Also, they announced a $30 million PIPE financing earlier today. That is after quarter end.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...